Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
49°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
734.97
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
77
78
Next >
Eli Lilly Unusual Options Activity
November 07, 2023
Via
Benzinga
Humana, Eli Lilly And A Major Mining Stock On CNBC's 'Final Trades'
November 07, 2023
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named Freeport-McMoRan Inc. (NYSE: FCX), adding that she likes the stock
Via
Benzinga
3 Ultra-Safe Dividend Stocks to Buy Hand Over Fist in November
November 07, 2023
These three blue chips ought to be reliable, long-term income generators.
Via
The Motley Fool
Eli Lilly, Power Generators Lead Top S&P 500 Performers Monday
November 06, 2023
Eli Lilly jumped, while energy plays were big winners and losers.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
What Happened With Eli Lilly and Company Stock Today?
November 06, 2023
Eli Lilly and Company (NYSE: LLY) shares traded higher on Monday.
Via
Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $500 Today
November 06, 2023
Via
Benzinga
Check Out What Whales Are Doing With LLY
November 03, 2023
Via
Benzinga
Eli Lilly Just Added Another Potential Billion-Dollar Product: Is It a Buy?
November 03, 2023
The answer is relatively clear.
Via
The Motley Fool
Why Eli Lilly Stock Is Jumping Today
November 02, 2023
Investors liked the drugmaker's Q3 update.
Via
The Motley Fool
Cathie Wood's ARK Innovation Just Had Its Best Week Ever Thanks To Roku, These Huge Winners
November 06, 2023
Roku vaulted 50% to become Ark Innovation's top holding.
Via
Investor's Business Daily
Week In Review: Hengrui Out-Licenses Next-Gen PARP1 To Merck KGaA For $1.7 Billion
November 04, 2023
Jiangsu Hengrui Pharma out-licensed global rights for its next-gen PARP1 inhibitor to Germany’s Merck KGaA for a $170 million upfront payment and up to $1.5 billion in milestones. Merck will have...
Via
Talk Markets
Fed Holds Rates Steady, Powell's Cautious Stance Soothes Investors, Labor Market Softens: The Week In The Markets
November 03, 2023
Markets bounced back decisively this week, shrugging off prior volatile months marked by heightened geopolitical tensions. The resurgence of risk sentiment ignited a relief rally in both equities and...
Via
Benzinga
Topics
Bonds
Economy
Exposures
Debt Markets
Interest Rates
The Importance of Brand Power: 3 Stocks to Consider
November 03, 2023
Count on these companies, whose reputations and brands are growing, leading their popular brand stocks to new heights.
Via
InvestorPlace
Eli Lilly Smashes Third-Quarter Forecasts As Diabetes Blockbuster Grows 652%
November 02, 2023
Mounjaro helped drive a third-quarter beat, growing sevenfold.
Via
Investor's Business Daily
Stock Market Rally Back In Force As Treasury Yields Plunge; Arista, Palantir Among Winners: Weekly Review
November 03, 2023
Bulls are back in control as the major indexes confirmed the uptrend this week.
Via
Investor's Business Daily
Ozempic Sales Soar 56% in Q3. But Is Eli Lilly a Better Stock to Buy Than Novo Nordisk?
November 03, 2023
Lilly's Mounjaro is gaining ground on Novo Nordisk's Ozempic.
Via
The Motley Fool
Eli Lilly (LLY) Q3 2023 Earnings Call Transcript
November 02, 2023
LLY earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Treasuries, Stocks Extend Gains Following Fed Meeting As Apple, Jobs Report Loom
November 02, 2023
(Thursday market open) The World Series is over, but Wall Street remains in the thick of this week’s triple play of a Fed meeting, Apple (NASDAQ: AAPL) earnings and Friday’s October jobs report. So...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Some Surprise Names Led The S&P 500 In October
November 02, 2023
The best and worst stock performers in the S&P 500 for October include some surprising names.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Weight Loss Drugs Drove Eli Lilly's Massive Profit - But They Still Cut Their Annual Profit Guidance, Here's Why
November 02, 2023
Eli Lilly And Co (NYSE: LLY) has reported Q3 sales of $9.49 billion, up 37% Y/Y, beating the consensus of $8.95 billion, dr
Via
Benzinga
Weight Watchers Q3 Earnings Preview: Will Ozempic Weigh Down WW Stock?
November 02, 2023
Weight Watchers stock, trading as WW, is already down 30% YTD. Here's what analysts will be watching in the Q3 earnings report.
Via
Benzinga
US Stocks On Track For Solid Start Amid Lingering Fed Optimism: Traders Eye Earnings From Market Bellwether Apple
November 02, 2023
After the Federal Reserve‘s decision, the stock market rally is poised to gain momentum on Thursday, with stock futures indicating an uptick.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
7 A-Rated Tech Stocks to Buy for November
November 02, 2023
By investing in tech stocks, investors can capitalize on groundbreaking technological advancements and be a part of the future.
Via
InvestorPlace
Fear Continues To Grip Markets After Fed's Rate Decision
November 02, 2023
The CNN Money Fear and Greed index remained in the "Fear" zone on Wednesday. U.S. stocks closed higher on Wednesday after the Federal Reserve maintained interest rates for a second straight time. Bond...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech
November 01, 2023
Market Bubbles may take a long time to clear and we created a big one in July 2021 dealing with the COVID pandemic.
Via
Talk Markets
Exposures
COVID-19
Earnings Due For Stealth GLP-1 Weight-Loss Drug Play McKesson, Rivals
November 01, 2023
McKesson earnings are on tap, with Cencora and Cardinal Health due soon.
Via
Investor's Business Daily
Inside Cathie Wood’s Portfolio: 3 Stocks She Is Betting Millions On
November 01, 2023
Are you looking to invest in disrupting stocks like Cathie Woods? Here are three stocks Cathie Wood is betting millions on.
Via
InvestorPlace
7 A-Rated Stocks to Buy in Q4
October 31, 2023
This is one of the best times of the year to look for stocks to buy, as the market historically shows an increase 80% of the time in Q4.
Via
InvestorPlace
Why Beam and Verve Therapeutics Shares Soared While Eli Lilly Soured Today
October 31, 2023
Lilly is putting its money where its mouth is with its purchase of cutting-edge medical technology.
Via
The Motley Fool
Ozempic Supply Is Running Low: Here's Why That Can Be A Problem
October 31, 2023
Ozempic, the diabetes drug also used as a so-called "miracle" weight-loss drug, has been sweeping through America and is now in limited supply.
Via
Benzinga
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
77
78
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.